Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO · BSE: 524518 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹61.19
Market cap: ₹131.9 Cr
Revenue (annual): ₹23.73 Cr
Net profit (annual): ₹-16.93 Cr
P/E (TTM): -9.9×Sector 43.8×
Promoter holding: 72.74%+0.00% QoQ
FII holding: 0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 1 Financial Results 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Oct 2026 13:00 IST BSE

Financial Results

Krebs Biochemicals & Industries Q2 FY27 Results: Net Loss of ₹5.4 Cr, Loss Narrows

Krebs Biochemicals reported Q2 FY27 standalone results with a net loss of Rs.539.85 Cr. The half-year loss widened to Rs.788.33 Cr amid Vizag unit closure.

Key figure: Net loss ₹5.4 Cr

Open full results → Read the filing ↗